Genfit S.A. | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2023

Income Metrics

Revenue 14.3M

Balance Sheet Metrics

Total Assets 151.4M
Total Liabilities 82.2M
Shareholders Equity 69.2M
Debt to Equity 1.19

Cash Flow Metrics

Revenue & Profitability Trend

Genfit S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i67.0M28.6M20.2M80.1M765.0K
Cost of Goods Sold i300.0K341.0K251.0K162.0K202.0K
Gross Profit i66.7M28.2M19.9M79.9M563.0K
Gross Margin % i99.6%98.8%98.8%99.8%73.6%
Operating Expenses
Research & Development i47.4M46.7M35.9M35.3M59.2M
Selling, General & Administrative i8.7M8.0M7.3M8.2M18.2M
Other Operating Expenses i7.0M307.0K3.9M3.6M236.0K
Total Operating Expenses i63.1M55.1M47.1M47.0M77.6M
Operating Income i3.2M-27.2M-27.3M32.4M-77.5M
Operating Margin % i4.8%-95.1%-135.3%40.4%-10,131.9%
Non-Operating Items
Interest Income i1.8M1.7M137.0K274.0K1.4M
Interest Expense i4.7M4.6M4.4M5.0M11.8M
Other Non-Operating Income791.0K72.0K7.2M6.2M-13.9M
Pre-tax Income i1.8M-28.5M-23.8M69.5M-101.6M
Income Tax i340.0K380.0K-116.0K2.2M-428.0K
Effective Tax Rate % i18.4%0.0%0.0%3.2%0.0%
Net Income i1.5M-28.9M-23.7M67.3M-101.2M
Net Margin % i2.2%-101.2%-117.4%84.0%-13,231.5%
Key Metrics
EBITDA i7.5M-22.3M-24.8M71.0M-72.4M
EPS (Basic) i-€-0.58€-0.48€1.51€-2.60
EPS (Diluted) i-€-0.58€-0.48€1.23€-2.60
Basic Shares Outstanding i-49700223494145834473975638858617
Diluted Shares Outstanding i-49700223494145834473975638858617

Income Statement Trend

Genfit S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i81.8M77.8M136.0M258.8M171.0M
Short-term Investments i-04.6M0-
Accounts Receivable i2.1M18.5M3.2M7.2M793.0K
Inventory i4.0K4.0K4.0K4.0K4.0K
Other Current Assets1.0K1.0K1.0K--
Total Current Assets i92.8M113.1M158.5M268.1M184.7M
Non-Current Assets
Property, Plant & Equipment i5.2M5.3M6.5M6.3M9.1M
Goodwill i48.0M48.8M44.0M174.0K297.0K
Intangible Assets i48.0M48.8M44.0M174.0K297.0K
Long-term Investments-----
Other Non-Current Assets353.0K530.0K0517.0K688.0K
Total Non-Current Assets i58.7M60.8M57.1M13.6M13.4M
Total Assets i151.4M173.9M215.5M281.7M198.1M
Liabilities
Current Liabilities
Accounts Payable i13.4M10.4M8.6M12.3M20.3M
Short-term Debt i56.6M7.9M5.1M2.2M4.3M
Current Portion of Long-term Debt-----
Other Current Liabilities-1.0K----1.0K
Total Current Liabilities i75.2M38.5M39.4M62.8M31.1M
Non-Current Liabilities
Long-term Debt i5.6M62.3M70.2M72.0M181.3M
Deferred Tax Liabilities i145.0K455.0K510.0K602.0K767.0K
Other Non-Current Liabilities--1.0K2.0K-
Total Non-Current Liabilities i7.0M67.4M81.6M99.8M183.5M
Total Liabilities i82.2M105.9M121.0M162.6M214.5M
Equity
Common Stock i12.5M12.5M12.5M12.5M9.7M
Retained Earnings i-390.6M-390.8M-361.3M-337.8M-405.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i69.2M68.0M94.5M119.1M-16.4M
Key Metrics
Total Debt i62.1M70.2M75.3M74.2M185.7M
Working Capital i17.6M74.6M119.1M205.3M153.6M

Balance Sheet Composition

Genfit S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i1.5M-28.9M-23.7M67.3M-101.2M
Depreciation & Amortization i1.7M1.7M1.8M2.7M3.6M
Stock-Based Compensation i610.0K578.0K245.0K470.0K1.2M
Working Capital Changes i8.4M-27.8M-54.8M59.7M-11.1M
Operating Cash Flow i15.5M-54.5M-72.3M101.5M-99.5M
Investing Activities
Capital Expenditures i-899.0K-242.0K271.0K-102.0K-900.0K
Acquisitions i00-41.5M0-
Investment Purchases i-140.0K-12.0K-5.0M-3.1M-66.0K
Investment Sales i04.6M00-
Investing Cash Flow i-1.0M4.3M-46.3M-3.3M-966.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i--000
Debt Issuance i089.0K015.3M207.0K
Debt Repayment i-10.3M-4.7M-1.7M-50.3M-2.2M
Financing Cash Flow i-10.6M-5.1M-3.8M-8.9M-494.0K
Free Cash Flow i14.6M-57.9M-72.6M99.4M-97.3M
Net Change in Cash i3.9M-55.3M-122.4M89.3M-100.9M

Cash Flow Trend

Genfit S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 124.80
Forward P/E -7.63
Price to Book 2.69
Price to Sales 2.71

Profitability Ratios

Profit Margin 2.13%
Operating Margin -293.86%
Return on Equity 2.20%
Return on Assets 1.15%

Financial Health

Current Ratio 1.23
Debt to Equity 89.76
Beta 1.28

Per Share Data

EPS (TTM) €0.03
Book Value per Share €1.39
Revenue per Share €1.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
gnft191.4M124.802.692.20%2.13%89.76
Abivax SA 4.6B-21.14-565.33-196.12%0.00%-16.16
Valneva SE 857.1M70.644.50-38.02%-34.15%105.63
Medincell S.A 584.8M--112.65%-66.50%-4.11
Inventiva S.A 536.1M-1.25-1.40172.73%0.00%-1.70
BNP Paribas Easy 463.1M15.99--96.39%-27.22%2.22

Financial data is updated regularly. All figures are in the company's reporting currency.